Erschienen in:
30.04.2020 | COVID-19 | Letters to the editor
Zur Zeit gratis
Extracorporeal membrane oxygenation in the treatment of respiratory failure during COVID‑19
verfasst von:
Prof. Dr. med. Junbo Ge
Erschienen in:
Herz
|
Ausgabe 4/2020
Einloggen, um Zugang zu erhalten
Excerpt
By April 14, 2020, a total of 1,819,465 confirmed COVID-19 cases with 115,103 deaths have been reported across the world. Clinically, the infection of the novel coronavirus mainly affects the respiratory system leading to pneumonia, while the virus may also cause other organ damage such as derangement of renal and liver functions, cardiac injury, cellular immune deficiency, and coagulation activation. Currently there are no specific drugs for COVID-19, which is a self-limiting disease requiring sufficient time for a rigorous immune response [
1]. …